391 related articles for article (PubMed ID: 7640237)
1. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
dos Santos Silva I; Swerdlow AJ
Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
[TBL] [Abstract][Full Text] [Related]
2. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
3. Ovarian and endometrial cancers.
Mant JW; Vessey MP
Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
[TBL] [Abstract][Full Text] [Related]
4. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.
Villard-Mackintosh L; Vessey MP; Jones L
Br J Obstet Gynaecol; 1989 Jul; 96(7):783-8. PubMed ID: 2788456
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in time trends of colorectal cancer in England and Wales: the possible effect of female hormonal factors.
dos Santos Silva I; Swerdlow AJ
Br J Cancer; 1996 Mar; 73(5):692-7. PubMed ID: 8605109
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
7. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract][Full Text] [Related]
8. Update on cancer control in women.
Boyle P; Maisonneuve P; Autier P
Int J Gynaecol Obstet; 2000 Aug; 70(2):263-303. PubMed ID: 10960611
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
10. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
[TBL] [Abstract][Full Text] [Related]
11. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
Michels KA; Pfeiffer RM; Brinton LA; Trabert B
JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
[TBL] [Abstract][Full Text] [Related]
12. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].
Veljković M; Veljković S
Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095
[TBL] [Abstract][Full Text] [Related]
13. Trends in cancer incidence and mortality in Scotland: description and possible explanations.
Swerdlow AJ; dos Santos Silva I; Reid A; Qiao Z; Brewster DH; Arrundale J
Br J Cancer; 1998; 77 Suppl 3(Suppl 3):1-54. PubMed ID: 9665378
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic--a correlation analysis.
Nischan P; Ebeling K
Int J Cancer; 1984 Nov; 34(5):671-4. PubMed ID: 6209226
[TBL] [Abstract][Full Text] [Related]
15. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
16. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use.
Gnagy S; Ming EE; Devesa SS; Hartge P; Whittemore AS
Epidemiology; 2000 Mar; 11(2):102-5. PubMed ID: 11021604
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
Vessey M; Yeates D
Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
[TBL] [Abstract][Full Text] [Related]
18. Endometrial and ovarian cancer and oral contraceptives--findings in a large cohort study.
Vessey MP; Painter R
Br J Cancer; 1995 Jun; 71(6):1340-2. PubMed ID: 7779735
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
Koper NP; Kiemeney LA; Massuger LF; Thomas CM; Schijf CP; Verbeek AL
Obstet Gynecol; 1996 Sep; 88(3):387-93. PubMed ID: 8752245
[TBL] [Abstract][Full Text] [Related]
20. The myth about contraceptives and breast cancer.
Ibekwe J
Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
